ATE216385T1 - Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen - Google Patents

Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen

Info

Publication number
ATE216385T1
ATE216385T1 AT95900419T AT95900419T ATE216385T1 AT E216385 T1 ATE216385 T1 AT E216385T1 AT 95900419 T AT95900419 T AT 95900419T AT 95900419 T AT95900419 T AT 95900419T AT E216385 T1 ATE216385 T1 AT E216385T1
Authority
AT
Austria
Prior art keywords
halopropen
nortropane
carboxyalkyl
fluorophenyl
substituted
Prior art date
Application number
AT95900419T
Other languages
English (en)
Inventor
David R Elmaleh
Bertha K Madras
Peter Meltzer
Robert N Hanson
Original Assignee
Gen Hospital Corp
Harvard College
Organix Inc
Univ Northeastern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Harvard College, Organix Inc, Univ Northeastern filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE216385T1 publication Critical patent/ATE216385T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K51/0448—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil tropane or nortropane groups, e.g. cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95900419T 1993-10-25 1994-10-24 Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen ATE216385T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/142,584 US5493026A (en) 1993-10-25 1993-10-25 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
PCT/US1994/012225 WO1995011901A1 (en) 1993-10-25 1994-10-24 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders

Publications (1)

Publication Number Publication Date
ATE216385T1 true ATE216385T1 (de) 2002-05-15

Family

ID=22500439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900419T ATE216385T1 (de) 1993-10-25 1994-10-24 Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen

Country Status (7)

Country Link
US (2) US5493026A (de)
EP (2) EP0734385B1 (de)
AT (1) ATE216385T1 (de)
DE (1) DE69430438T2 (de)
DK (1) DK0734385T3 (de)
ES (1) ES2172571T3 (de)
WO (1) WO1995011901A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750089A (en) 1996-01-11 1998-05-12 Neuro Imaging Technologies, Llc Halogenated neuroprobe for mapping monoamine reuptake sites
US5493026A (en) * 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
JP3731005B2 (ja) * 1995-06-06 2006-01-05 ジーイー ヘルスケア リミテッド モノアミン再取込み部位をマッピングするためのヨウ素標識ニューロプローブ
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US6171576B1 (en) * 1995-11-03 2001-01-09 Organix Inc. Dopamine transporter imaging agent
US7105678B2 (en) 1995-11-03 2006-09-12 Organix, Inc. Boat tropanes
US7081238B2 (en) * 1995-11-03 2006-07-25 The President And Fellows Of Harvard College Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
FR2748475B1 (fr) * 1996-05-10 1999-04-16 Cis Bio Int Derives du tropane utilisables en particulier pour la detection in vivo des transporteurs de la dopamine
US7214686B2 (en) * 1997-06-30 2007-05-08 Targacept, Inc. Pharmaceutical compositions and methods for effecting dopamine release
US6001330A (en) * 1997-09-12 1999-12-14 Elmaleh; David R. Diagnostic and therapeutic alkylenediamine compounds and process
US6525386B1 (en) * 1998-03-10 2003-02-25 Masimo Corporation Non-protruding optoelectronic lens
US6344179B1 (en) 1999-04-22 2002-02-05 Emory University Fluoralkenyl nortropanes
US7553478B2 (en) * 1999-05-12 2009-06-30 President And Fellows Of Harvard College Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
US20100143248A1 (en) * 1999-06-28 2010-06-10 President And Fellows Of Harvard College Methods for diagnosing and monitoring treatment of adhd by assessing the dopamine transporter level
US6440970B1 (en) 2000-05-25 2002-08-27 Targacept, Inc. Pharmaceutical compositions and methods for use
JP2003534344A (ja) 2000-05-25 2003-11-18 ターガセプト，インコーポレイテッド ニコチン性コリン受容体リガンドとしてのヘテロアリールジアザビシクロアルカン
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
DE20120708U1 (de) 2001-10-09 2002-08-01 Blundell, Paul, Sommerville, Mass. Tropan-Analoga zur Inhibierung des Monoamin-Transports
CA2480742A1 (en) * 2002-03-28 2003-12-04 President And Fellows Of Harvard College Tropane compounds
JP4611017B2 (ja) * 2002-04-30 2011-01-12 エモリー ユニバーシティー 腫瘍画像化化合物
WO2005037832A2 (en) * 2003-10-15 2005-04-28 Targacept, Inc. Azabicycyclic compounds for relieving pain and treating central nervous system disorders
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
AU2006262502A1 (en) 2005-06-23 2007-01-04 Emory Univerisity Imaging agents
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
US7732607B2 (en) * 2005-08-22 2010-06-08 Anatoly Mazurov Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
US8017785B2 (en) 2006-05-09 2011-09-13 Astrazeneca Ab Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
TWI454262B (zh) * 2006-11-02 2014-10-01 Targacept Inc 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
TW200845977A (en) * 2007-03-30 2008-12-01 Targacept Inc Sub-type selective azabicycloalkane derivatives
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
EP2209497B1 (de) * 2007-09-26 2017-11-22 Philips Intellectual Property & Standards GmbH Verbindungen zur verwendung in einer methode zur differenzierten diagnose durch spect von verschiedenen typen von demenz
EP2212319B1 (de) 2007-10-31 2018-07-18 Alseres Pharmaceuticals, Inc. Formulierung von markiertem, iodiertem tropan
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
EP2242364A4 (de) * 2008-01-15 2011-09-21 Targacept Inc Zubereitung und enantiomere trennung von 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonan und neue salzformen des racemats und der enantiomere
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
WO2009108376A2 (en) 2008-02-29 2009-09-03 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
JP2011513421A (ja) * 2008-03-05 2011-04-28 ターガセプト，インコーポレイテッド サブタイプ選択的なジアザビシクロアルカンのアミド
EP3231804B1 (de) 2008-03-21 2021-03-03 The General Hospital Corporation Verbindungen und zusammensetzungen für den nachweis und die behandlung von morbus alzheimer und verwandten erkrankungen
DE102008047314B4 (de) * 2008-09-16 2012-08-30 Johannes Gutenberg-Universität Mainz Radioaktiv-markierte Cyclopropan-Derivate DAT-affiner Tropane
US9145396B2 (en) 2008-12-01 2015-09-29 Targacept, Inc. Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
WO2010065443A1 (en) 2008-12-01 2010-06-10 Targacept, Inc. Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
US8802694B2 (en) 2009-12-07 2014-08-12 Targacept, Inc. 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
DK3323810T3 (da) 2010-02-08 2022-03-28 Lantheus Medical Imaging Inc Automatiseret reaktionssystem, kassette og indretning til syntese af billeddannelsesmidler
MX337106B (es) 2010-05-27 2016-02-12 Targacept Inc Antagonistas no competitivos de receptores nicotinicos.
WO2012125518A1 (en) 2011-03-14 2012-09-20 Targacept, Inc. Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane
TW201311698A (zh) 2011-08-22 2013-03-16 Targacept Inc 作為神經元菸鹼乙醯膽鹼受體配位體之１，４－二氮雜雙環［３．２．２］壬烷
CN108484449A (zh) 2011-09-09 2018-09-04 蓝瑟斯医学影像公司 用于合成和使用显像剂的组合物、方法和系统
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods
WO2018148509A1 (en) * 2017-02-10 2018-08-16 Likeminds, Inc. Methods for in vivo monitoring of dopaminergic disorders and efficacy of treatment agents therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452029A (en) * 1966-11-21 1969-06-24 American Home Prod 3-alpha-phenylbenzyloxy - 8 - substituted nortropanes and their substitutents
US5496953A (en) * 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US5310912A (en) * 1992-02-25 1994-05-10 Research Biochemicals Limited Partnership Iodinated neuroprobe for mapping monoamine reuptake sites
US5268480A (en) * 1992-09-22 1993-12-07 Mayo Foundation For Medical Education And Research Cocaine analogs
US5493026A (en) * 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders

Also Published As

Publication number Publication date
DE69430438T2 (de) 2002-11-21
EP1081147A2 (de) 2001-03-07
WO1995011901A1 (en) 1995-05-04
EP0734385A4 (de) 1997-05-07
DK0734385T3 (da) 2002-08-05
ES2172571T3 (es) 2002-10-01
DE69430438D1 (de) 2002-05-23
EP0734385B1 (de) 2002-04-17
EP0734385A1 (de) 1996-10-02
US5493026A (en) 1996-02-20
US5853696A (en) 1998-12-29

Similar Documents

Publication Publication Date Title
ATE216385T1 (de) Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen
AU5292290A (en) Diagnostic method for alzheimer&#39;s disease: examination of non-neural tissue
AU2414092A (en) Diagnostic method for alzheimer&#39;s disease
AU3891499A (en) Diagnostic tests for alzheimer&#39;s disease
PT1110542E (pt) Dosagem diaria de metoprolol por via oral
ATE236115T1 (de) Dimer-selektive rxr modulatoren und verfahren zu ihrer verwendung
DK0393838T3 (da) Dopaminreceptorligander og imagografimidler
FR2670669B1 (fr) Instrument de correction chirurgicale de l&#39;astigmatisme.
EP0524984A4 (en) Lipophilic contrast agents for diagnostic image analysis
HUP0003684A3 (en) Diagnostic test for alzheimer&#39;s disease
ATE172956T1 (de) Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen
EP1767224A3 (de) Stereoisomers von Fettsäureanalogen für diagnostische Bildgebung
ATE293391T1 (de) Verfahren zur verbesserung der auflösung einer nuklearmedizinischen aufnahme
BR9406806A (pt) Instrumento (laringoscópio) para exposiçao da área da garganta de um paciente
PT86654A (pt) Substituierte 3-phenyl-7h-thiazolo]3,2-b&#34; ]1,2,4&#34;triazin-7-one verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
DE69414129D1 (de) Biphenyl jodierte derivate und ihre verwendung als diagnostikum
AU4781193A (en) Clinical test for detection of alzheimer&#39;s disease
AU2990692A (en) Diagnostic method for pompe&#39;s disease
GB9323826D0 (en) Diagnosis of alzheimer&#39;s disease
ATE157970T1 (de) Dopamin-rezeptor-liganden und bilderzeugungsmittel
AU718732C (en) Diagnostic assay for Alzheimer&#39;s disease
AU3518897A (en) Diagnostic assay for Alzheimer&#39;s disease
ES2148731T3 (es) Agentes de contraste para rayos x destinados a la tomografia por ordenador y a la urografia.
ITMI911450A1 (it) Endoapparecchio per il ripristino dell&#39;articolazione coxofemorale
GB9517266D0 (en) Diagnosis of alzheimer&#39;s disease